Omthera Pharmaceuticals Inc (NASDAQ:OMTH) Investor Alert: Investigation of Buyout by AstraZeneca
An investigation on behalf of investors in Omthera Pharmaceuticals Inc (NASDAQ:OMTH) shares was announced concerning whether the offer by AstraZeneca to acquire Omthera Pharmaceuticals Inc for $12.70 per NASDAQ:OMTH share and the takeover process are unfair to investors in NASDAQ:OMTH shares.
View full press release